Compare HLN & AMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | AMP |
|---|---|---|
| Founded | 2022 | 1894 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7B | 42.1B |
| IPO Year | N/A | 2005 |
| Metric | HLN | AMP |
|---|---|---|
| Price | $9.51 | $474.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $542.50 |
| AVG Volume (30 Days) | ★ 8.9M | 590.6K |
| Earning Date | 07-31-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.90% | 1.35% |
| EPS Growth | ★ 41.64 | 39.94 |
| EPS | 0.23 | ★ 36.43 |
| Revenue | $15,096,588,575.00 | ★ $18,513,000,000.00 |
| Revenue This Year | $1.51 | $2.24 |
| Revenue Next Year | $4.67 | $6.11 |
| P/E Ratio | $41.67 | ★ $13.01 |
| Revenue Growth | N/A | ★ 6.12 |
| 52 Week Low | $8.71 | $396.14 |
| 52 Week High | $11.42 | $582.05 |
| Indicator | HLN | AMP |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 60.28 |
| Support Level | $9.69 | $447.92 |
| Resistance Level | $9.77 | $460.54 |
| Average True Range (ATR) | 0.14 | 10.91 |
| MACD | -0.03 | 3.61 |
| Stochastic Oscillator | 4.55 | 91.55 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With more than $1 trillion in segment assets under management and advisory at year-end 2024, and with roughly 10,000 affiliated advisors, Ameriprise is one of the larger US-based wealth managers. The firm also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $645 billion in assets under management at year-end 2024. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.5 trillion in assets under management and advisory across segments at year-end 2024.